AC Immune (ACIU) Depreciation & Amortization (CF) (2015 - 2025)
AC Immune (ACIU) posted Depreciation & Amortization (CF) of $411,635 for the quarter ended Dec 31, 2025, up 0.4% from $409,806 a year earlier but down 3.2% from the prior quarter.
Powered by 
Analysis
AC Immune (ACIU) Depreciation & Amortization (CF) (2015 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, AC Immune's Depreciation & Amortization (CF) came in at $1.68 million, down 0.5% from the prior year.
- Annual Depreciation & Amortization (CF) has declined for four consecutive years, though with a five-year compound annual growth rate of 0.5% (years ended Dec 2020 to Dec 2025).
- In prior years, AC Immune's Depreciation & Amortization (CF) was $1.69 million in the year ended Dec 31, 2024 (-9.3%), $1.86 million in the year ended Dec 31, 2023 (-1.0%), $1.88 million in the year ended Dec 31, 2022 (-9.5%) and $2.08 million in the year ended Dec 31, 2021 (+26.8%).
- Quarterly Depreciation & Amortization (CF) has run from a low of $401,522 in the quarter ended Mar 31, 2025 to a high of $539,119 in the quarter ended Sep 30, 2021 over five years.
- On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last three quarters, with an average decline of 4.9% over the last eight quarters.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was the quarter ended Jun 30, 2021, with growth of 37.1%; the weakest was the quarter ended Sep 30, 2022, with a decline of 15.9%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $425,037 (quarter ended Sep 30, 2025), $438,464 (quarter ended Jun 30, 2025) and $401,522 (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | AC Immune | 266.56 Mn | 266.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 411,634.86 |
| Sep 30, 2025 | 425,037.23 |
| Jun 30, 2025 | 438,464.15 |
| Mar 31, 2025 | 401,522.44 |
| Dec 31, 2024 | 409,806.34 |
| Sep 30, 2024 | 414,360.40 |
| Jun 30, 2024 | 417,989.94 |
| Mar 31, 2024 | 445,670.42 |
| Dec 31, 2023 | 470,106.82 |
| Sep 30, 2023 | 467,579.01 |
| Jun 30, 2023 | 451,543.27 |
| Mar 31, 2023 | 471,386.88 |
| Dec 31, 2022 | 479,566.12 |
| Sep 30, 2022 | 453,530.01 |
| Jun 30, 2022 | 449,580.87 |
| Mar 31, 2022 | 498,091.85 |
| Dec 31, 2021 | 527,068.02 |
| Sep 30, 2021 | 539,118.91 |
| Jun 30, 2021 | 520,907.38 |
| Mar 31, 2021 | 487,772.05 |
API Access
AC Immune Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();